The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
Abstract
BACKGROUND: Inactivation of the tumor suppressor gene PTEN/MMAC1/TEP1, located on chromosome 10q23, is a common event in advanced stages of diverse human malignancies. However, the prognostic role of PTEN expression in patients with hepatocellular carcinoma (HCC) has not been characterized. METHODS: One hundred five resected specimens were collected from patients with HCC. Expression levels of PTEN and p53 in clinical samples were analyzed by immunohistochemistry. RESULTS: Immunohistochemical analysis of 105 HCC tissue specimens revealed that decreased or absence of PTEN immunostaining was found in 43 specimens (40.9%). Reduced PTEN expression levels were correlated with increased tumor grade (P = 0.017), advanced disease stage (P = 0.016), and elevated serum α‐fetoprotein (αFP) levels (P = 0.001). Kaplan–Meier analysis indicated that patients with reduced PTEN levels had shorter overall survival (P = 0.001) and higher recurrence rates (P = 0.0007) compared with patients who had intact PTEN expression. Examining p53 expression unveiled an inverse correlation between p53 overexpression and reduced PTEN expression in patients with HCC (P = 0.004). In addition, patients with p53 overexpression had shorter overall survival compared with patients who were without p53 overexpression (P = 0.0014). Univariate and multivariate analyses revealed that reduced PTEN expression was an independent prognostic factor for survival in patients with HCC. CONCLUSIONS: The current study demonstrated that reduced PTEN expression levels are involved in the pathogenesis of HCC. Moreover, decreased PTEN expression was correlated with tumor progression, high αFP levels, p53 overexpression, and poor prognosis in patients with HCC. Cancer 2003;97:1929–40. © 2003 American Cancer Society. DOI 10.1002/cncr.11266
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
(2000) · PubMed · Cited by 1,445
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Self-citationLi, D., & Sun, H. (1997) · PubMed · Cited by 866
Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774
McMenamin, M. E., Soung, P., Perera, S., Kaplan, I. D., Loda, M. F., & Sellers, W. R. (1999) · PubMed · Cited by 640
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 590
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., & Ozturk, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1973 · Cited by 416
Xu, X.-R., Huang, J., Xu, Z.-G., Qian, B.-Z., Zhu, Z.-D., Yan, Q., Cai, T., Zhang, X., Xiao, H.-S., Qu, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241522398 · Cited by 365
PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy
Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108302200 · Cited by 351
Gimm, O., Perren, A., Weng, L.-P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65040-7 · Cited by 327
Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer
Depowski, P. L., Rosenthal, S. I., & Ross, J. S. (2001) · Modern Pathology · doi:10.1038/modpathol.3880371 · Cited by 294
Dahia, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 274
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
(1999) · PubMed · Cited by 258
A Role for Nuclear PTEN in Neuronal Differentiation
Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01404.2000 · Cited by 230
Allelotype study of primary hepatocellular carcinoma
藤森, 実. (1991) · Medical Entomology and Zoology · doi:10.11501/3089422 · Cited by 221
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J. B., Morimoto, A. M., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., et al. (1998) · PubMed · Cited by 188
Allelotype study of primary hepatocellular carcinoma.
Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., & Harada, H. (1991) · PubMed · Cited by 170
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., & Maeda, S. (1994) · PubMed · Cited by 135
Loss of PTEN Expression as a Prognostic Marker for Tongue Cancer
Lee, J. I., Soria, J., Hassan, K. A., El‐Naggar, A. K., Tang, X., Liu, D. D., Hong, W. K., & Mao, L. (2001) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.127.12.1441 · Cited by 126
PTEN/MMAC1 mutations in hepatocellular carcinomas
Yao, Y. J., Ping, X. L., Zhang, H., Chen, F. F., Lee, P. K., Ahsan, H., Chen, C., Lee, P., Peacocke, M., Santella, R. M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202659 · Cited by 121
Tachibana, M., Shibakita, M., Ohno, S., Kinugasa, S., Yoshimura, H., Ueda, S., Fujii, T., Rahman, M. A., Dhar, D. K., & Nagasue, N. (2002) · Cancer · doi:10.1002/cncr.0678 · Cited by 104
Marsh, D. J., Dahia, P. L. M., Coulon, V., Zheng, Z., Dorion-Bonnet, F., Call, K. M., Little, R., Lin, A. Y., Eeles, R. A., Goldstein, A. M., et al. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6 · Cited by 100
Chest wall resection in the treatment of locally recurrent breast carcinoma
Faneyte, I. F., Rutgers, E. J. T., & Zoetmulder, F. A. �. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<865::aid-cncr6>3.0.co;2-k · Cited by 70
Fujiwara, Y., Hoon, D. S. �., Yamada, T., Umeshita, K., Gotoh, M., Sakon, M., Nishisho, I., & Monden, M. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00943.x · Cited by 59
Is the p53 Gene Mutation of Prognostic Value in Hepatocellular Carcinoma After Resection?
Jeng, K. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.11.1329 · Cited by 58
Rahman, M. A., Kyriazanos, I. D., Ono, T., Yamanoi, A., Kohno, H., Tsuchiya, M., & Nagasue, N. (2002) · International Journal of Cancer · doi:10.1002/ijc.10458 · Cited by 58
Tian, X.-X., Pang, J. C., To, S. S. T., & Ng, H. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199905000-00006 · Cited by 56
PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
Kawamura, N., Nagai, H., Bando, K., Koyama, M., Matsumoto, S., Tajiri, T., Onda, M., Fujimoto, J., 植木, 孝., Konishi, N., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00763.x · Cited by 54
Overexpression of p53 in hepatocellular carcinomas: A clinicopathological and prognostic correlation
Ng, I. O., Lai, E. C. S., Chan, A. S. Y., & So, M. K. P. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01089.x · Cited by 44
Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells
Adachi, J.-I., Ohbayashi, K., Suzuki, T., & Sasaki, T. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.91.5.0822 · Cited by 41
Mutation Analysis of the Putative Tumor Suppressor GenePTEN/MMAC1in Hepatocellular Carcinoma
Yeh, K.-T., Chang, J., Chen, Y., Chen, S., Yu, S., Shih, M., Perng, L.-L., Wang, J., Tsai, M., & Chang, C. (2000) · Cancer Investigation · doi:10.3109/07357900009038243 · Cited by 27
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
Metadata
- Authors
- Hu, T., Huang, C., Lin, P., Chang, H., Ger, L., Lin, Y., Changchien, C., Lee, C., & Tai, M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 97
- Issue
- 8
- Pages
- 1929-1940
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2144469062
- Cited by
- 277
- References
- 38
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.